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Abstract
Background: Genome-wide association studies have been used extensively to identify genetic variants linked to
metabolic syndrome (MetS), but most of them have been conducted in non-Asian populations. This study aimed
to evaluate the association between MetS and previously studied single nucleotide polymorphisms (SNPs), and
their interaction with health-related behavior in Korean men.
Methods: Seventeen SNPs were genotyped and their association with MetS and its components was tested in
1193 men who enrolled in the study at Seoul National University Hospital.
Results: We found that rs662799 near APOA5 and rs769450 in APOE had significant association with MetS and its
components. The SNP rs662799 was associated with increased risk of MetS, elevated triglyceride (TG) and low
levels of high-density lipoprotein, while rs769450 was associated with a decreased risk of TG. The SNPs showed
interactions between alcohol drinking and physical activity, and TG levels in Korean men.
Conclusions: We have identified the genetic association and environmental interaction for MetS in Korean men.
These results suggest that a strategy of prevention and treatment should be tailored to personal genotype and
the population.
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Background
According to a World Health Organization report, car-
diovascular diseases were the cause of 30 % of all deaths
globally in 2008 and the number of deaths is constantly
increasing [1]. Metabolic syndrome (MetS) is a cluster of
health conditions, which are strongly associated with the
incidence of cardiovascular diseases and mortality [2–4].
The age-adjusted prevalence of MetS was 31.3 % [5],
and a population-attributable fraction of MetS for car-
diovascular disease was 12–17 % in Korean [6]. Thus,
MetS is one of the most important current public health
problems in Korea.
MetS is caused by multiple genetic and environmental
risk factors, and an interaction between the factors has
been widely postulated. Among the environmental fac-
tors, lifestyle factors such as a caloric excess diet and a
sedentary lifestyle are important risk factors for MetS
[7]. However, there is also evidence of the role of hered-
ity for risk of MetS. Large proportion of variance of
MetS components were associated with narrow-sense
heritability explained by common SNPs (46 % for waist
hip ratio, 30 % for glucose metabolism, 34 % for trigly-
ceride, 25 % for HDL and 80 % for SBP) [8].
Genome-wide association studies (GWASs) have been
used extensively to identify common genetic variants
linked to MetS. Most of these variants were located in the
genes involved in lipid metabolism (PPARG rs1801281,
APOA5 rs662799, APOC3 rs2854117, CETP rs708272,
GNB3 rs5433 and APOE rs7412) [9]. Some of these single
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nucleotide polymorphisms (SNPs) were also associated
with weight regulation, glucose metabolism and blood
pressure. In addition, FTO rs9939609 was associated with
weight regulation, and TCF7L2 rs7903146 was involved in
glucose metabolism [9].
However, most previous studies were conducted mainly
in western populations. Few studies have been conducted
in Asian populations of the association between MetS
and its components, and specific loci [9, 10]. To our
knowledge, no study has been conducted to evaluate
the association between various genetic variants and
MetS in Koreans. Furthermore, the interplay between
health-related behaviors as environmental factors and
genetic factors has not been fully evaluated in previous
association studies. Thus, this study aimed to evaluate
the association between previously studied SNPs and
MetS, and the interaction between health-related be-
haviors and SNPs in Korean men. We hypothesized
that genetic variants which were known to be related to
MetS or its components in other population would be
associated with MetS in Koreans, and this association
would be modified by health-related behaviors.
Results
Population characteristics
Descriptive characteristics of the 254 participants with
MetS and 939 control participants included in this
study are shown in Table. 1. As expected, participants
with MetS showed significantly increased risk levels for
all of the MetS component variables (Waist circumfer-
ence, high density lipoprotein, triglyceride, fasting glu-
cose, systolic blood pressure and diastolic blood
pressure) and BMI (P < 0.001). Of the health-related
behaviors, participants with MetS showed higher expos-
ure to smoking and drinking than controls, but their
patterns of physical activity were similar.
Genetic associations
A list of genotyped SNPs is provided in Additional file 1:
Table S1. The association of 17 SNPs with MetS and its
components was tested using logistic regression analysis.
After a basic adjustment (model 1), one SNP (rs662799)
near APOA5 showed the most significant association
with increased risk of elevated triglyceride (TG) levels
(P = 3.25 × 10−6), low levels of high-density lipoprotein
(HDL) (P = 7.20 × 10−4), and MetS (P = 2.90 × 10−4). An-
other SNP (rs769450) in APOE showed significant asso-
ciation (P = 0.0015) with decreased levels of TG (Table 2,
and Additional file 1: Tables S2 and S3).
After model 1 adjustments, linear regression analysis
revealed that rs662799 of APOA5 was significantly as-
sociated with elevated TG levels (P = 1.27 × 10−6) and
low levels of HDL (P = 4.22 × 10−4) (Additional file 1:
Table S4). The rs769450 polymorphism of APOE was
found to be moderately associated with decreased TG
levels, but the association was not significant after
Bonferroni adjustment.
The significantly associated TG and HDL levels, and
MetS prevalence are shown in Fig. 1, according to the
genotype of rs662799 and rs769450. A significantly addi-
tive effect of rs662799 is shown for TG and HDL levels,
and MetS prevalence, because it increased the risk of
MetS. A moderate additive effect is shown for rs7694450
for decreased TG levels and MetS prevalence.
Table 1 Characteristics of study subjects
Characteristics Case with MetS Control P-value
Mean ± SD or
number (%)
Mean ± SD or
number (%)
Total number 254 939
Age (years) 47.55 ± 6.56 47.92 ± 6.99 0.454
BMI (kg/m2) 26.43 ± 2.49 23.72 ± 2.43 <0.001
MetS components
WC (cm) 94. 23 ± 6.38 85.92 ± 6.88 <0.001
HDL cholesterol
(mg/dL)
44.09 ± 11.60 52.29 ± 11.49 <0.001
Triglyceride
(mg/dL)
209. 16 ± 90.55 107.31 ± 57.42 <0.001
Fasting glucose
(mg/dL)
105.87 ± 22.08 90.60 ± 12.99 <0.001
SBP (mmHg) 131.22 ± 13.08 120.95 ± 13.55 <0.001
DBP (mmHg) 83.90 ± 10.38 76.50 ± 9.85 <0.001
Health-related behaviors
Smoking 0.017
Non smoker 46 (18.1 %) 217 (23.1 %)
Former smoker 92 (36.2 %) 367 (39.1 %)
Current smoker 116 (45.7 %) 355 (37.8 %)
Drinking 0.002
Non drinker 39 (15.4 %) 176 (18.7 %)
Light drinker 85 (33.5 %) 373 (39.7 %)
Moderate
drinker
40 (15.7 %) 157 (16.7 %)




Low level 109 (44.9 %) 379 (41.3 %)
Moderate level 87 (35.8 %) 341 (37.1 %)
High level 47 (19.3 %) 198 (21.6 %)
P-value represents the significance of the difference between case with MetS
and control. All continuous variables were compared using t test. Health-
related behaviors were assessed according to the linear-by-linear association
of chi-square test
BMI body mass index, MetS Metabolic syndrome, WC waist circumference, HDL
high density lipoprotein, SBP systolic blood pressure, DBP diastolic blood
pressure, SD standard deviation
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Table 2 The logistic regression results of significant SNPs for MetS and its components
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MetS components cut-off: WC >90 Cm for men, TG > 150 mg/dL, HDL < 40 mg/dL, BP: SBP > 130 mmHg or DBP > 85 mmHg, Glucose > 100 mg/dL
Bold indicates significance of Bonfferoni adjusted P-value (<0.0029)
WC waist circumference, TG triglyceride, HDL high density lipoprotein, BP blood pressure, MetS Metabolic syndrome
aModel 1: Adjusted for age and region of recruitment















Health-related behavior and genotype-stratified analysis
We conducted a multiple regression analysis with two
adjustment models (model 1: age and region of recruit-
ment; model 2: age, region of recruitment, smoking, alco-
hol and physical activity). We obtained a more significant
result after health-related behaviors were included in the
adjustment (model2) (Table 2). All health-related behav-
iors were significantly associated with TG levels (data not
shown). We analyzed the relationship between the two
SNPs significantly associated with TG levels within strati-
fied levels of health-related behaviors (Fig. 2, Additional
file 1: Figure S1). We compared TG levels between major
homozygous genotype vs the sum of heterozygous and
minor homozygous genotypes, because of the lower num-
ber of minor homozygous genotypes.
First, participants were stratified according to their
smoking status. Regarding rs662799, the group with
the risk allele (AG and GG genotypes) showed higher
levels of TG than the reference (AA genotype) group
did at all levels of smoking, especially for ex-smokers
(P = 0.0004) and current smokers (P = 0.0041) (Fig. 2a).
However, we could not find any interaction between
smoking and the rs662799 genotype (Additional file 1:
Figure S1A). Regarding rs769450, the AA and AG ge-
notypes showed a protective effect by decreasing the
TG levels compare with the reference (GG genotype)
for all smoking exposure; however, only ex-smokers
showed significantly different levels of TG (P = 0.023),
and a specific interaction between smoking and
rs769450 was not found (Additional file 1: Figure S1B).
Second, participants were stratified by level of exposure
to alcohol. Regarding rs662799, AG and GG genotype
showed higher TG levels compare with the reference (AA
genotype), except in moderate drinkers. The reference
group (AA genotype) exhibited lower TG levels in non-
and light drinker, whereas TG levels were dramatically
increased in moderate drinkers. The group with risk allele
(AG and GG genotype) showed similar TG levels in non-,
light and moderated drinkers, whereas TG levels were in-
creased in heavy drinkers. Regarding rs769450, TG levels
Fig. 1 The additive effect of rs662799 and rs769450. TG, HDL level and MetS prevalence according to the (a) rs662799 and (b) rs769450 genotypes.
The P-values of TG and HDL were estimated via linear regression analysis and MetS prevalence was estimated via logistic regression analysis. All
analyses were adjusted for age and region of recruitment (Model1). HDL: high density lipoprotein, TG: triglyceride
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were decreased in non-, light and moderate drinkers in
the group with the AA and AG genotype, in contrast to
participants in the group with the reference (GG geno-
type). Consequentially, in moderate drinkers, significantly
different (P = 4.72 × 10−5) levels of TG were found accord-
ing to the rs769450 variant.
Third, we evaluated the differences in TG levels ac-
cording to genotype and stratified physical activity. Re-
garding rs662799, participants in the group that carried
the AG and GG genotypes had significantly higher TG
levels compared with those with reference (AA geno-
type) in the low (P = 0.0006) and moderate (P = 0.0011)
physical activity groups. However, individuals with the
AG and GG genotypes and high levels of physical activity
showed dramatically decreased levels of TG. Regarding
rs769450, participants with low physical activity in the
group that carried the AA and AG genotypes showed
similar TG levels compare with those of reference (GG
genotype). However, a more pronounced decrease in the
levels of TG were found in the group with the AA and
AG genotypes in cases with increased levels of physical
activity (P = 0.027 and 0.013, moderate and high physical
activity, respectively).
Discussion
We have demonstrated that SNPs in APOA5 and APOE
were significantly associated with MetS and its components
in the Korean men who participated in this study.
We also evaluated the interaction between these
SNPs and health-related behaviors affecting the
levels of TG.
Generally, SNPs of APOA5 are associated with dys-
lipidemia, which is a component of MetS [9, 11]. Four
common SNPs (rs662799, rs2266788, rs3135506 and
rs2072560) verified in the APOA5 gene, are associated
with increased TG levels [12]. Among these SNPs,
rs662799 is located in the promotor region of APOA5
gene, which is strongly associated with elevated TG
levels, and confers risk for MetS and stroke [13, 14]. In
Koreans, there is an association between rs662799, a
risk of MetS and increased susceptibility to diabetes
mellitus [15, 16].
In this study, we found that rs662799, which is located
near APOA5, was significantly associated with levels of
TG, HDL and the prevalence of MetS in Korean men
(Table 2). The minor allele frequency (MAF) of rs662799
was 0.293, which is similar to that in Koreans (0.302) and
Chinese (0.284 and 0.304), but higher than the frequency
reported in Europeans (0.095) [15, 17, 18]. A study of
Koreans [15] showed that, among the MetS compo-
nents, TG and HDL were equally significantly associ-
ated with rs662799, with a weak association (P = 0.015;
odds ratio [OR], 1.285) between MetS and rs662799 in
men. However, we found more significant association
Fig. 2 Significant SNPs and their interaction with health-related behaviors. TG levels in participants with (a) rs662799 and (b) rs769450 genotypes
associated with stratified levels of smoking, drinking and physical activity. Asterisks indicate the significance of the differences in TG levels
between each genotype (t-test, *P < 0.05, **P < 0.01, and ***P < 0.001). All error bars represent standard errors. Stratified drinking cutoff levels,
alcohol (g)/week: nondrinker = 0; light drinker <98 g; moderate drinker >98 g but <196 g; and heavy drinker ≥196 g. PA: physical activity,
TG: triglyceride
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(P = 2.9 × 10−4; OR, 1.498; model 1) between MetS and
rs662799 in men (Table 2).
The APOA5 3′-UTR variant, rs2266788, is associated
with plasma TG levels through downregulation of APOA5
[19]. In the present study, the APOA5 SNP, rs2266788,
showed marginal association with TG and MetS. After
multiple testing correction, this SNP was found to be sig-
nificantly associated with TG, but only in adjustment
model2 (Additional file 1: Tables S2 and S3).
APOE functions in the catabolism of chylomicron rem-
nants and very low-density lipoprotein from plasma. Two
common SNPs located in APOE exon 4 (rs429358 and
rs7412) encode three APOE isoforms (E2, E3 and E4).
These isoforms have been studied extensively and found
to contribute to MetS, cardiovascular disease, hypertri-
glyceridemia and ischemic stroke [20–24]. However, other
common variants have not yet been sufficiently explored.
The common APOE intron SNP, rs769450, was associated
with low-density lipoprotein in Europeans-Americans and
African-Americans [25]. To our knowledge, the associ-
ation between rs769450 and MetS or TG levels has not
been reported.
In the present study, we found that rs769450 of APOE is
significantly associated with TG levels. A protective effect
was shown for rs769450, not only for TG levels, but also
moderately for MetS (Fig. 1b). The MAF of rs769450 was
0.202 and lower than the frequency in Europeans (0.437)
[26]. A number of studies of APOE have focused on two
common SNPs (rs429358 and rs7412) on exon 4, which
make three APOE isoforms. These three APOE isoforms
show a significant association with TG levels and MetS in
various populations. In a Japanese study of 1788 partici-
pants, rs7412 was found to be associated with MetS
[27]. However, we could not find any significant associ-
ation between rs7412 and MetS (P = 0.6362) or TG
level (P = 0.2782).
Although it seemed that there was no interaction
between cigarette smoking and APOA5 rs662799 and
APOE rs769450, we found interactions between the
genotypes and alcohol drinking and physical activity
that affected TG levels. The difference between TG
levels was narrowed for participants with APOA5
rs662799, but widened for APOE rs769450 in mo-
derate drinkers, and participants with high levels of
physical activity.
Regarding rs662799, participants in the group with
the AG and GG genotypes had similar levels of TG
whether they were non-, light, or moderate drinkers.
However, moderate drinkers in the group with the AA
genotype showed significantly increased levels of TG
(Additional file 1: Figure S1A). The difference in TG
level between participants with different SNPs was in-
significant for moderate drinkers. We observed that the
levels of TG were dramatically decreased in participants
in the group with the AG and GG genotypes of rs662799
and high levels of physical activity.
Regarding rs769450, the AA and AG genotypes had a
protective effect in non-, light and moderate drinkers,
who showed marginally decreased TG levels. High
levels of physical activity had more benefit in decreas-
ing TG levels in participants with the AA and AG ge-
notypes than in those without them. This finding
regarding physical activity is consistent with clinical
guidelines, which recommend physical activity to re-
duce cardiovascular diseases, and indicate that high
levels of physical activity should be emphasized in gen-
eral. We found that variants of rs769450 had more
benefit in decreasing TG levels in those participants
who drank moderately and had high levels of physical
activity, than in those without this variant.
Although moderate drinking and high physical activ-
ity could be recommended in general, we can assume
that these behaviors are of greater benefit in people
with specific genotypes. In this study, participants with
variant SNPs of APOA5 and APOE showed a greater
decrease in TG levels when they exhibited these behav-
iors. Therefore, tailored consultation for health-related
behaviors should be considered if genetic information
is available in clinical situations.
Together, our findings show that rs667799 and rs769450
are significantly associated with elevated or decreased
levels of TG, respectively and MetS in Korean men. In
Koreans, the MAF of the risk SNP (rs662799) is higher,
and the MAF of the protective SNP (rs769450) is lower
than in Europeans. Consequently, East Asians, including
Koreans, are more exposed to the risk of MetS than Euro-
peans. Thus, in Korean men, a tailored approach that
addresses environmental factors is important in order to
overcome the unfavorable genetic predisposition.
Despite variants of APOA5 and APOE revealing an
increase in the risk of MetS in Koreans, other SNPs that
are associated with MetS in other populations were not
shown to be significantly associated with MetS or its
components in Koreans after multiple test correction.
These findings suggest that susceptibility to MetS is
different in various populations according to their geno-
types. Therefore, effective strategies for the prevention
and treatment of MetS may differ according to the geno-
type and environmental factors in each population.
A limitation of this study was that we only tested the
associations in men. According to the study design, we
could not evaluate the same association in the general
population or only in women. Further studies with more
participants, including women, are warranted to validate
our results. Recall bias should also be considered, be-
cause data on health-related behavior were collected via
a self-administered questionnaire. In addition, we could
not infer temporary relationship because this study was
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cross-sectional study, so that causality could not be con-
firmed. And other potential confounders related to MetS
such as nutritional information including nutriceuticals,
were not available, we could not include such variables
in analysis.
Conclusions
In conclusion, rs662799 of APOA5 and rs769450 of
APOE were significantly associated with regulated TG
levels and MetS in the Korean men we studied. These
SNPs appeared to interact with alcohol drinking and
physical activity, thereby affecting TG levels. Because
East Asians, including Koreans, more frequently have
these risk SNPs than Europeans, strategies for the pre-
vention of MetS and its treatment should be tailored to
personal genotype and health-related behaviors.
Methods
Study design and population
We conducted a cross-sectional study designed to evalu-
ate the association between genetic variants and bio-
logical markers such as anthropometric measurement,
visceral fat, MetS components. The participants in this
study were general males who visited the Health Promo-
tion Center and Healthcare System Gangnam Center at
Seoul National University Hospital from December 2009
to December 2013.
Patients visited the center to undergo a periodic
health checkup and every patient met a physician before
the health checkup. They completed a self-administered
questionnaire, which included questions on health-
related behaviors. Participants were informed about the
study before their health checkup, and asked to partici-
pate. Written informed consent was obtained by their
physician.
Every single male patient under 60 years who visited the
centers for regular health checkup and received abdominal
computed tomography in the period was asked to partici-
pate in this study. Patients were excluded from study
when they did not agree to participate in this study, had
thyroid functional diseases, took medication or treatment
regarding weight control, diabetes mellitus or psychiatric
diseases, experienced weight change over 10 % of their
weight for last 3 months, or had comorbidity such as dia-
betes mellitus, coronary heart diseases, cerebrovascular
diseases and cancers except skin cancers.
Totally 1563 patients agreed to participate in this study
and we obtained informed consent from these patients.
Among them, 54 patients were excluded from analysis.
Twenty six patients were excluded because it was found
that they were over 60 years, 20 patients were excluded
because of medication history or comorbidities, 7 patients
were excluded because of duplication. In addition, we
excluded 317 patients who took medication for
hypertension or hypercholesterolemia. Finally 1193 pa-
tients were included in analysis. Anthropometric measure-
ments and laboratory tests were conducted as part of a
general health checkup, and genomic DNA was extracted
from peripheral blood leukocytes of all participants using
the QuickGene DNA whole-blood kit with QuickGene-
610 L equipment (Fujifilm, Tokyo, Japan), according to
standard protocols. The study protocol was approved by
the Institutional Review Board (approval number, H-0911-
010-299) of the Seoul National University Hospital, Korea.
Phenotype measurement
Eligible participants completed a questionnaire designed
for clinical purposes, which included the following ques-
tions: (a) demographic details (sex, age, household income,
education and marital status); (b) comorbidities and medi-
cation for conditions including hypertension, diabetes
mellitus and hypercholesterolemia; and (c) health-related
behavior (cigarette smoking, alcohol drinking and physical
activity).
Body weight and height were measured with light
clothing and no shoes. Body mass index (BMI) was
calculated as body weight (in kg) divided by the square
of height (in m2). Waist circumference was measured
from the narrowest point between the lowest point of
the rib and the highest point of the iliac crest. Blood
pressure (BP) was measured in a sitting position at least
5-min rest period. The second and third systolic and dia-
stolic blood pressure were averaged for this analysis.
Blood sample was taken in the morning with at least 8 h
of fasting state. All blood samples were taken on the
same day.
A consensus definition of MetS for clinical diagnosis
was proposed by International Diabetes Federation
Task Force in 2009 [28], and we used this definition.
According to the definition, MetS could be diagnosed if
patients had three or more of the following five MetS
features: increased waist circumference, in which we used
the Korean obesity criterion (≥90 cm) in place of the
original criterion (≥94 cm) [29]; low levels of HDL choles-
terol (<40 mg/dL); elevated levels of TG (≥150 mg/dL);
elevated blood pressure (≥130/85 mmHg); and elevated
glucose levels (≥100 mg/dL). We excluded patients who
took medication for hypertension, hypercholesterolemia,
or diabetes mellitus.
For health-related behavior, current cigarette smoking,
problem alcohol drinking and physical inactivity were
defined as risky health-related behaviors. According to
National Health Interview Survey, participants who had
smoked more than 100 cigarettes in their lifetime, and
smoked every day or on some days were defined as
current smokers [30]. Those who had smoked more than
100 cigarettes and stopped smoking were defined as ex-
smokers. In line with definition of National Institute on
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Alcohol Abuse and Alcoholism, we defined moderate
alcohol consumption as up to 2 drinks per day, where a
drink was 14 g of alcohol [31]. In addition we defined
light drinkers as less than 1 drink per day to examine
dose—response relation. Therefore men who drank
≥196 g of alcohol per week were defined as heavy
drinkers; men who drank ≥98 g but <196 g of alcohol
were defined as moderate drinkers; and men who
drank <98 g were defined as light drinkers. Physical
activity was measured as daily physical activity using
the Korean version of the International Physical Activ-
ity Questionnaire-Short Form (IPAQ-SF), which was
translated into Korean and validated [32]. Physical ac-
tivity was categorized as low, moderate, or high using
the IPAQ scoring protocol [33].
SNP selection and genotyping
A total of 17 SNPs with a MAF of less than 0.05 in the
Asian HapMap (CHB + JPT) were selected to test asso-
ciations with MetS and its components (Additional file
1: Table S1). Among selected SNPs, PPARG rs1801281,
APOA5 rs662799, rs2266788 CETP rs708272, rs1800775
GNB3 rs5433, APOE rs769450, rs7412 FABP2 rs1799883
and ENPP1 rs1044498 are involved in lipid metabolism [9,
19, 25, 34–36]. Some of these SNPs are also involved in
weight regulation, glucose metabolism and blood pres-
sure regulation. In addition, LMNA rs4641 is involved
in insulin resistance and glucose metabolism [37]. LEPR
rs1137101 is associated with circulatory leptin level,
while ADIPOQ rs1501299, rs2241766 and rs266729 are
associated with circulatory adiponectin [38]. ADRB2
rs1042714 and ADRB3 rs4994 are in genes that encode
the β-adrenoreceptor and mediate the action of cate-
cholamines, respectively [39, 40]. All SNPs were geno-
typed using TaqMan assays and a ViiA7 genotyping
system (Applied Biosystems, Foster City, CA). To main-
tain the quality of the genotyping data, a genotyping
call rate > 95 % and Hardy-Weinberg equilibrium P > 0.01
were considered.
Statistics
We conducted the genetic association analysis between
the chosen SNPs and MetS and its components via an
additive model using PLINK software, version 1.07 [41].
Logistic regression analysis was used to test the associ-
ation between each SNP and MetS risk categorized
groups, adjusted using two different methods (model 1:
age and region of recruitment; model 2: age, region of
recruitment, smoking, alcohol and physical activity). A lin-
ear regression analysis was conducted to investigate the
association between chosen SNPs and quantitative MetS
risk phenotypes in the whole cohort, with adjustment for
the same models. A Bonferroni-adjusted P < 0.0029 (0.05/
17 SNPs) was considered significant for the multiple test.
For interaction analysis, TG level was compared between
each genotype among same stratified health-related be-
haviors (Fig. 2) and between each stratified health-related
behaviors among same genotype (Additional file 1: Figure
S1) using a t-test. Demographic data arrangement and
interaction with health-related behaviors were analyzed
using IBM SPSS Statistics for Windows, version 20 (IBM
Corp., Armonk, NY, USA).
Additional file
Additional file 1: Table S1. The list of selected SNPs. Table S2. The
logistic regression results for MetS and its components (Model 1).
Table S3. The logistic regression results for MetS and its components
(Model 2). Table S4. The linear regression results of significant
SNPs for quantitative trait of MetS components. Figure S1. TG level
difference between health-related behaviors. (DOCX 75 kb)
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